Congenital nephrotic syndrome and recurrence of proteinuria after renal transplantation

Pediatric Nephrology

Volumn 29, Issue 12, 2014, Pages 2309-2317

  Holmberg, Christer ^a   Jalanko, Hannu ^a  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

Anti nephrin antibodies; Congenital nephrotic syndrome; Renephrosis; Rituximab

Indexed keywords

EID: 84896689301     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-014-2781-z     Document Type: Article

References (46)

1. Jalanko H, Holmberg C (2009) Congenital nephrotic syndrome. In: Avner D-D, Harmon W-E, Niaudet P, Yoshikawa N (eds) Pediatric Nephrology, 6th edn. Springer, Berlin Heidelberg New York, pp S601–S619
2. Agati VD, Kaskel FJ, Falk RJ (2011) Focal segmental glomerulosclerosis. N Engl J Med 365:2398–2411
3. Ahvenainen EK, Hallman N, Hjelt L (1956) Nephrotic syndrome in newborn and young infants. Ann Paediatr Fenn 2:227–241
4. Kestilä M, Lenkkeri U, Männikkö M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K (1998) Positionally cloned gene for a novel protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell 1:575–582
5. Ruotsalainen V, Ljungberg P, Wartiovaara J, Lenkkeri U, Kestilä M, Jalanko H, Holmberg C, Tryggvason K (1999) Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci USA 96:7962–7967
6. Patrakka J, Tryggvason K (2007) Nephrin—a unique structural and signalling protein of the kidney filter. Trends Mol Med 13:396–403
7. Patrakka J, Kestilä M, Wartiovaara J, Ruotsalainen V, Tissari P, Lenkkeri U, Männikkö M, Visapää I, Holmberg C, Rapola J, Tryggvason K, Jalanko H (2000) Congenital nephrotic syndrome (NPHS1): features resulting from different mutations in Finnish patients. Kidney Int 58:972–980
8. Holmberg C, Antikainen M, Rönnholm K, Ala-Houhala M, Jalanko H (1995) Management of congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 9:87–93
9. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C (2000) NPHS2, encoding the glomerular podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24:349–354
10. Machuca E, Benoit G, Nevo F, Tête M-J, Gribouval O, Pawtowski A, Brandström P, Loirat C, Niaudet P, Gubler M-C, Antignac C (2010) Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome. J Am Soc Nephrol 21:1209–1217
11. Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F, members of the Arbeitsgemeinschaft fuer Pediatrische Nephrologie Study group (2007) Nephrotic syndrome in the first year of life: two-thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119:e907–E919
12. Gbadegesin R, Hinkes BG, Hoskins BE, Vlangos CN, Heeringa SF, Liu J, Loirat C, Ozaltin F, Hashmi S, Ulmer F, Cleper R, Ettenger R, Antingac C, Wiggins RC, Zenker M, Hildebrandt F (2008) Mutations in PLCE1 are major cause of isolated diffuse mesangial sclerosis (IDMS). Nephrol Dial Transplant 23:1291–1297
13. Jeanpierre C, Denamur E, Henry I, Cabanis MO, Luce S, Cécille A, Elion J, Peuchmaur M, Loirat C, Niaudet P, Gubler MC, Junien C (1998) Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet 62:824–833
14. Zenker M, Aigner T, Wendler O, Tralau T, Muntefering H, Fenski R, Pitz S, Schumacher V, Royer-Pokora B, Wuhl E, Cochat P, Bouvier R, Kraus C, Mark K, Madlon H, Dotsch J, Rascher W, Maruniak-Chudek I, Lennert T, Neumann LM, Reis A (2004) Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 13:2625–2632
15. Diomedi-Camassei F, Di Giandomenico S, Santorelli FM, Cardini G, Piemonte F, Montini G, Ghiggeri GM, Murer L, Barisoni L, Pastore A, Muada AO, Valente ML, Bertini E, Emma F (2007) COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 18:2773–2780
16. Heeringa S, Chernin G, Chaki M, Zhou W, Sloan AJ, Ji Z, Xie LX, Salviati L, Hurd TW, Vega-Warner V, Killen PD, Raphael Y, Ashraf S, Ovunc B, Schoeb DS, McLaughlin HM, Airik R, Vlangos CN, Gbadegesin R, Hinkes B, Saisawat P, Trevisson E, Doimo M, Casarin A, Pertegato V, Giorgi G, Prokisch H, Rötig A, Nuernberg G, Becker C, Wang S, Ozaltin F, Topaloglu R, Bakkaloglu A, Bakkaloglu SA, Mueller D, Beissert A, Mir S, Berdeli A, Özen S, Zenker M, Matejas V, Santos-Ocaña C, Navas P, Kusakabe T, Kispert A, Akman S, Soliman NA, Krick S, Mundel P, Reiser J, Nuernberg P, Clarke CF, Wiggins RC, Faul C, Hildebrandt F (2011) COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest 121:2013–2024
17. Gupta IR, Baldwin C, Auguste D, Ha KCH, Andalousi JE, Fahimiya S, Bitzan M, Bernard C, Akbari MR, Narod SA, Rosenblatt DS, Majewski J, Takano T (2013) ARGHDIA: a novel gene implicated in nephrotic syndrome. J Med Genet 50:330–338
18. Gee HY, Saisawat P, Ashraf S, Hurd TW, Vega-Werner V, Fang H, Beck BB, Gribouval O, Zhou W, Diaz KA, Natarajan S, Wiggins RC, Lovric S, Chernin G, Schoeb DS, Uvunc B, Frishberg Y, Soliman NA, Fathy HM, Goebel H, Hoefele J, Weber LT, Innis JW, Faul C, Han Z, Washburn J, Antignac C, Levy S, Otto EA, Hildebrandt F (2013) ARGHDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J Clin Invest 123:3243–3253
19. Smith JM, Matz K, Blydt-Hansen TD (2013) Pediatric kidney transplant practice patterns and autcome benchmarks, 1987–2010: A report of the North American Pediatric Renal Trials and Collaborative Studies. Pediatr Transplant 17:149–157
20. Foster BJ, Dahhou M, Zhang X, Platt RW, Samuel SM, Hanley JA (2011) Association between age and graft failure rates in young kidney transplant recipients. Transplantation 92:1237–1243
21. Hertelius M, Celsi G, Edström Halling S, Krmar RT, Sandberg J, Tydén G, Åsling- Monemi K, Berg U (2012) Renal transplantation in infants and small children. Pediatr Nephrol 27:145–150
22. Patzer RE, Amaral S, Klein M, Kutner N, Perryman JP, Gazmararian JA, McCellan WM (2012) Racial disparities in pediatric access to kidney transplantation: does socioeconomic status play a role? Am J Transplant 12:369–378
23. Gondos A, Döhler B, Brenner H, Opelz G (2013) Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation 95:267–274
24. Salvatierra O Jr, Singh T, Shiffrin R, Conley S, Alexander S, Tanney D, Lemley K, Sarwal M, Mackie F, Alfrey E, Orlandi P, Zarins C, Hefkens R (1998) Successful transplantation of adult-size kidneys into infants requires maintenance of high aortic blood flow. Transplantation 66:819–823
25. Mehls O, Fine RN (2013) Growth hormone treatment after renal transplantation: a promising but underused chance to improve growth. Pediatr Nephrol 28:1–4
26. Tainio J, Qvist E, Vehmas R, Jahnukainen K, Hölttä T, Valta H, Jahnukainen T, Jalanko H (2011) Pubertal development is normal in adolescents after renal transplantation in childhood. Transplantation 92:404–409
27. Laakkonen H, Taskinen S, Rönnholm K, Holmberg C, Sandberg S (2014) Parent-child and spousal relationship in families with a young child with end-stage renal disease. Pediatr Nephrol 29:289–295
28. Kumar J, Shatat IF, Skversky AL, Woroniecki RP, Del Rio M, Perelstein EM, Johnson VL, Mahesh S (2013) Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis. Pediatr Nephrol 28:333–338
29. Bertelli R, Ginevri F, Caridi G, Dagnino M, Sandrini S, Di Luca M, Emma F, Sanna- Cherchi S, Scolari F, Neri TM, Murer L, Massella L, Basile G, Rizzoni G, Perfumo F, Ghiggeri GM (2003) Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 41:1314–1321
30. Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chadhuri A, Daftarin P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J (2011) Circulating urokinase receptor as a cause of focal segmental glomerusclerosis. Nat Med 17:952–960
31. Bitzan M, Babayeva S, Vasudevan A, Goodyear P, Torban E (2012) TNFα pathway blockade ameliorate toxic effects of FSGS plasma on podocyte cytoskeleton and 3 integrin activation. Pediatr Nephrol 27:2217–2226
32. Laine J, Jalanko H, Holthöfer H, Krogerus L, Rapola J, von Willebrand E, Lautenschlager I, Salmela K, Holmberg C (1993) Post-transplant nephrosis in congenital nephrotic syndrome of the Finnish type. Kidney Int 44:867–874
33. Sigström L, Hansson S, Jodal U (1989) Long-term survival of a girl with congenital nephrotic syndrome and recurrence of proteinuria after transplantation (abstr). Pediatr Nephrol 3:C169
34. Lane PH, Schnaper HW, Vernier RL, Bunchman TE (1991) Steroid-dependent nephrotic syndrome following renal transplantation for congenital nephrotic syndrome. Pediatr Nephrol 5:300–303
35. Flynn JT, Schulman SL, Dechaderevian J-P, Dunn SP, Kaiser BA, Polinsky MS, Baluarte HJ (1992) Treatment of steroid-resistant post-transplant nephrotic syndrome with cyclophosphamide in a child with congenital nephrotic syndrome. Pediatr Nephrol 6:553–555
36. Patrakka J, Ruotsalainen V, Reponen P, Qvist E, Laine J, Holmberg C, Tryggvason K, Jalanko H (2002) Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type. Transplantation 73:394–403
37. Kashtan CE (1999) Alport syndrome: an inherited disorder of renal, ocular and cochlear basement membranes. Medicine 78:338–360
38. Kuusniemi A-M, Qvist E, Sun Y, Patrakka J, Rönnholm K, Karikoski R, Jalanko H (2007) Plasma exchange and retransplantation in recurrent nephrosis of patients with congenital nephrotic syndrome of the Finnish type. Transplantation 83:1316–1323
39. Srivastava T, Garola RE, Kestilä M, Tryggvason K, Ruotsalainen V, Sharma M, Savin V, Jalanko H, Warady B (2006) Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 21:711–718
40. Chauduri A, Kambham N, Sutherland S, Grimm P, Alexander S, Conception W, Sarwal M, Wong C (2012) Rituximab treatment for recurrence of nephrotic syndrome in a paediatric patient after renal transplantation for congenital nephrotic syndrome of the Finnish type. Pediatric Transplant 16:E183–E187
41. Billing H, Muller D, Ruf R, Lichtenberger A, Hildebrandt F, August C, Querfeld U, Haffner D (2004) NPHS2 mutation associate with recurrence of proteinuria after transplantation. Pediatr Nephrol 19:561–564
42. Becker-Cohen R, Bruschi M, Rinat C, Feinstein S, Zennaro C, Ghicceri G, Frishberg Y (2007) Recurrent nephrotic syndrome in homozygous truncating NPHS2 mutation is not due to anti-podocin antibodies. Am J Transplant 7:256–260
43. Weber S, Gribouval O, Esquivel E, Moriniere V, Tete M, Legendre C, Niaudet P, Antignac C (2004) NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 66:571–579
44. Höcker B, Knuppel T, Waldherr R, Schaefer F, Weber S, Tönshoff B (2006) Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus. Pediatr Nephrol 21:1476–1479
45. Carraro M, Caridi G, Bruschi M, Arter M, Bertelli R, Zennaro C, Musante L, Candiano G, Perfumo F, Ghiggeri G (2002) Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13:1946–1952
46. Niaudet P (2010) Living donor kidney transplantation in patients with hereditary nephropathies. Nat Rev Nephrol 6:736–743